Accepting applications for 2025-26 in August 2023.
The Cancer Imaging Program (CIP) Fellowship at Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) provides a comprehensive education in body imaging (chest and abdomen), including MRI, CT, PET-CT, and US, with an emphasis on adult patients with cancer. Dana-Farber Cancer Institute is a world-renowned cancer center, Harvard Medical School teaching affiliate, and provides subspecialty adult clinical care jointly with Brigham and Women's Hospital.
The CIP Fellowship provides a comprehensive experience in body imaging, with fellows’ time equally divided between thoracic and abdominal subspecialties throughout the year. For interested applicants, dedicated time in PET-CT is also available (see below). Fellows receive one-on-one, onsite training from jointly appointed, subspecialized BWH/DFCI faculty across multiple imaging modalities including CT, MRI, and ultrasound.
The MRI curriculum focuses on advanced cancer-related abdomen and pelvis applications (1.5T and 3T systems) including prostate, rectal, hepatobiliary, female pelvis, and MR urography, among others.
Interpreting and protocoling initial cancer staging CT scans and oncologic follow-ups are the focus of the thoracic and abdominal CT experiences.
Ultrasound assignments cover routine abdominal, male and female pelvic/genitourinary, thyroid, basic vascular (DVT), and superficial soft tissue exams.
Additional experience in reading inpatient and general CT and MRI examinations is also available throughout the workday and on-call, making the CIP fellowship a comprehensive body imaging experience.
Clinical coverage responsibility for fellows includes weekday and day-time weekend clinical coverage at the DFCI Longwood campus and rotating weekday coverage at the new, state-of-the-art Dana-Farber Chestnut Hill campus.
In addition to continual one-on-one teaching throughout the day, ample protected time for formal didactics includes:
Weekly CIP seminar series (designated for Category 1 CME credit) covering comprehensive topics in cancer imaging
Extensive database of pre-recorded lectures to supplement learning
In addition, fellows have the opportunity to develop their own teaching skills through participation in resident lectures and reading room education.
Dedicated research time is available for fellows submitting approved research projects in conjunction with an attending radiologist as project mentor. Research time may begin two months after the start of the fellowship and is contingent on clinical coverage and project approval by the Fellowship Program Director. Assistance in identifying projects and research mentors can be provided as necessary. Research milestone schedules are clearly articulated at the start of the project and research progress is monitored on a continuous basis throughout the year.
Up to four weeks of the CIP Fellowship may be used as elective time which may be spent in other radiology disciplines within BWH or as additional time for approved research. Meeting time can also be granted for accepted research.
PET-CT Clinical Fellowship
This clinical fellowship track will provide physicians with advanced clinical imaging training in oncology with a focus on PET-CT, molecular imaging, evaluation of novel therapeutic drugs, and new PET radiopharmaceuticals. The PET-CT Clinical Fellowship is offered in a 12-month or 3-month tracks with the latter tracks’ remaining months spent in general cancer imaging, CT, MR and US.
U.S. applicants must be board-eligible or board-certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with fellowship regulations as provided by the Department of Radiology at Brigham and Women's Hospital.
Applicants can upload their C.V., personal statement, photograph, USMLE scores and reference contact information at BWH/DFCI Cancer Fellowship Application. Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations. Other foreign applicants must send ECFMG certification. Applicants selected for interviews will be contacted individually by the program director.
We are committed to the fairness and consistency of the recruiting process and will adhere to the 2023 SCARD embargo guidelines. All interviews will be conducted virtually. We will start accepting applications for the 2025-2026 CIP Fellowship on November 1, 2023. Interviews will start no earlier than January 8, 2024. Exceptions to this embargo include international candidates, internal candidates, military candidates, and applicants whose spouse/domestic partner is also applying for fellowship in the same year.
We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status, or any other characteristic protected by law.
Lauren Roller, MD, Cancer Imaging Fellowship Program Director Dana-Farber Cancer Institute, Department of Imaging (DL101) 450 Brookline Avenue Boston, MA 02215 Attention: Ashley Watterson